Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 13, 40

Comparative Effectiveness of Cognitive Behavioral Therapy for Insomnia: A Systematic Review


Comparative Effectiveness of Cognitive Behavioral Therapy for Insomnia: A Systematic Review

Matthew D Mitchell et al. BMC Fam Pract.


Background: Insomnia is common in primary care, can persist after co-morbid conditions are treated, and may require long-term medication treatment. A potential alternative to medications is cognitive behavioral therapy for insomnia (CBT-I).

Methods: In accordance with PRISMA guidelines, we systematically reviewed MEDLINE, EMBASE, the Cochrane Central Register, and PsycINFO for randomized controlled trials (RCTs) comparing CBT-I to any prescription or non-prescription medication in patients with primary or comorbid insomnia. Trials had to report quantitative sleep outcomes (e.g. sleep latency) in order to be included in the analysis. Extracted results included quantitative sleep outcomes, as well as psychological outcomes and adverse effects when available. Evidence base quality was assessed using GRADE.

Results: Five studies met criteria for analysis. Low to moderate grade evidence suggests CBT-I has superior effectiveness to benzodiazepine and non-benzodiazepine drugs in the long term, while very low grade evidence suggests benzodiazepines are more effective in the short term. Very low grade evidence supports use of CBT-I to improve psychological outcomes.

Conclusions: CBT-I is effective for treating insomnia when compared with medications, and its effects may be more durable than medications. Primary care providers should consider CBT-I as a first-line treatment option for insomnia.


Figure 1
Figure 1
PRISMA flow diagram for literature search and article inclusion.

Similar articles

See all similar articles

Cited by 78 PubMed Central articles

See all "Cited by" articles


    1. Shochat T, Umphress J, Israel AG, Ancoli-Israel S. Insomnia in primary care patients. Sleep. 1999;22(Suppl 2):S359–S365. - PubMed
    1. Terzano MG, Parrino L, Cirignotta F, Ferini-Strambi L, Gigli G, Rudelli G, Sommacal S. Studio Morfeo Committee. Studio morfeo: Insomnia in primary care, a survey conducted on the Italian population. Sleep Med. 2004;5:67–75. doi: 10.1016/j.sleep.2003.09.006. - DOI - PubMed
    1. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6:97–111. doi: 10.1053/smrv.2002.0186. - DOI - PubMed
    1. Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, Lombardo C, Riemann D. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011;135:10–19. doi: 10.1016/j.jad.2011.01.011. - DOI - PubMed
    1. Morin CM, Belanger L, LeBlanc M, Ivers H, Savard J, Espie CA, Merette C, Baillargeon L, Gregoire JP. The natural history of insomnia: a population-based 3-year longitudinal study. Arch Intern Med. 2009;169:447–453. doi: 10.1001/archinternmed.2008.610. - DOI - PubMed

MeSH terms